Drug loaded implantable devices to treat cardiovascular disease

Masoud Adhami, Niamh K. Martin, Ciara Maguire, Aaron J. Courtenay, Ryan F. Donnelly, Juan Domínguez-Robles*, Eneko Larrañeta*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

21 Downloads (Pure)


It is widely acknowledged that cardiovascular diseases (CVDs) continue to be the leading cause of death globally. Furthermore, CVDs are the leading cause of diminished quality of life for patients, frequently as a result of their progressive deterioration. Medical implants that release drugs into the body are active implants that do more than just provide mechanical support; they also have a therapeutic role. Primarily, this is achieved through the controlled release of active pharmaceutical ingredients (API) at the implementation site.

Areas covered
In this review, the authors discuss drug-eluting stents, drug-eluting vascular grafts, and drug-eluting cardiac patches with the aim of providing a broad overview of the three most common types of cardiac implant.

Expert opinion
Drug eluting implants are an ideal alternative to traditional drug delivery because they allow for accurate drug release, local drug delivery to the target tissue, and minimise the adverse side effects associated with systemic administration. Despite the fact that there are still challenges that need to be addressed, the ever-evolving new technologies are making the fabrication of drug eluting implants a rewarding therapeutic endeavour with the possibility for even greater advances.

Original languageEnglish
Number of pages16
JournalExpert Opinion on Drug Delivery
Early online date28 Mar 2023
Publication statusEarly online date - 28 Mar 2023


  • cardiac patches
  • implantable devices
  • cardiovascular stents
  • vascular grafts
  • Cardiovascular disease


Dive into the research topics of 'Drug loaded implantable devices to treat cardiovascular disease'. Together they form a unique fingerprint.

Cite this